The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists

. 2015 Apr 21 ; 15 (4) : 9265-76. [epub] 20150421

Jazyk angličtina Země Švýcarsko Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid25905697

The constitutive androstane receptor (CAR) is a critical nuclear receptor in the gene regulation of xenobiotic and endobiotic metabolism. The LanthaScreen(TM) TR-FRET CAR coactivator assay provides a simple and reliable method to analyze the affinity of a ligand to the human CAR ligand-binding domain (LBD) with no need to use cellular models. This in silico assay thus enables the study of direct CAR ligands and the ability to distinguish them from the indirect CAR activators that affect the receptor via the cell signaling-dependent phosphorylation of CAR in cells. For the current paper we characterized the pharmacodynamic interactions of three known CAR inverse agonists/antagonists-PK11195, clotrimazole and androstenol-with the prototype agonist CITCO (6-(4-chlorophenyl)imidazo[2,1-b][1,3] thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime) using the TR-FRET LanthaScreen(TM) assay. We have confirmed that all three compounds are inverse agonists of human CAR, with IC50 0.51, 0.005, and 0.35 μM, respectively. All the compounds also antagonize the CITCO-mediated activation of CAR, but only clotrimazole was capable to completely reverse the effect of CITCO in the tested concentrations. Thus this method allows identifying not only agonists, but also antagonists and inverse agonists for human CAR as well as to investigate the nature of the pharmacodynamic interactions of CAR ligands.

Zobrazit více v PubMed

Carazo Fernandez A., Smutny T., Hyrsova L., Berka K., Pavek P. Chrysin, baicalein and galangin are indirect activators of the human constitutive androstane receptor (CAR) Toxicol. Lett. 2015;233:68–77. doi: 10.1016/j.toxlet.2015.01.013. PubMed DOI

Chai X., Zeng S., Xie W. Nuclear receptors PXR and CAR: Implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin. Drug Metab. Toxicol. 2013;9:253–266. doi: 10.1517/17425255.2013.754010. PubMed DOI

Jiang M., Xie W. Role of the constitutive androstane receptor in obesity and type 2 diabetes: A case study of the endobiotic function of a xenobiotic receptor. Drug Metab. Rev. 2013;45:156–163. doi: 10.3109/03602532.2012.743561. PubMed DOI

Wada T., Gao J., Xie W. PXR and CAR in energy metabolism. Trends Endocr. Metab. 2009;20:273–279. doi: 10.1016/j.tem.2009.03.003. PubMed DOI

Ingraham H.A., Redinbo M.R. Orphan nuclear receptors adopted by crystallography. Curr. Opin. Struct. Biol. 2005;15:708–715. doi: 10.1016/j.sbi.2005.10.009. PubMed DOI

Osabe M., Negishi M. Active ERK1/2 protein interacts with the phosphorylated nuclear constitutive active/androstane receptor (CAR; NR1I3), repressing dephosphorylation and sequestering CAR in the cytoplasm. J. Biol. Chem. 2011;286:35763–35769. doi: 10.1074/jbc.M111.284596. PubMed DOI PMC

Mutoh S., Sobhany M., Moore R., Perera L., Pedersen L., Sueyoshi T., Negishi M. Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. Sci. Signal. 2013;6:ra31. doi: 10.1126/scisignal.2003705. PubMed DOI PMC

Yang H., Wang H. Signaling control of the constitutive androstane receptor (CAR) Protein Cell. 2014;5:113–123. doi: 10.1007/s13238-013-0013-0. PubMed DOI PMC

Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., Stoltz C.A., Kliewer S.A., Lambert M.H., Willson T.M., Moore J.T. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 2003;278:17277–17283. doi: 10.1074/jbc.M300138200. PubMed DOI

Moore L.B., Parks D.J., Jones S.A., Bledsoe R.K., Consler T.G., Stimmel J.B., Goodwin B., Liddle C., Blanchard S.G., Willson T.M., Collins J.L., Kliewer S.A. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 2000;275:15122–15127. doi: 10.1074/jbc.M001215200. PubMed DOI

Li L., Chen T., Stanton J.D., Sueyoshi T., Negishi M., Wang H. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol. Pharmacol. 2008;74:443–453. doi: 10.1124/mol.108.046656. PubMed DOI PMC

Forman B.M., Tzameli I., Choi H.S., Chen J., Simha D., Seol W., Evans R.M., Moore D.D. Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta. Nature. 1998;395:612–615. doi: 10.1038/26996. PubMed DOI

LanthaScreen™ TR-FRET Constitutive Androstane Receptor Coactivator Assay Manual. Invitrogen Corporation; Carlsbad, CA, USA: 2007. Manufacturer’s_Manual, Invitrogen, Assay Pharmacology.

Kupcho K.R., Stafslien D.K., DeRosier T., Hallis T.M., Ozers M.S., Vogel K.W. Simultaneous monitoring of discrete binding events using dual-acceptor terbium-based LRET. J. Am. Chem. Soc. 2007;129:13372–13373. doi: 10.1021/ja074791h. PubMed DOI

Zhang J.H., Chung T.D., Oldenburg K.R. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999;4:67–73. doi: 10.1177/108705719900400206. PubMed DOI

Kenakin T., Williams M. Defining and characterizing drug/compound function. Biochem. Pharmacol. 2014;87:40–63. doi: 10.1016/j.bcp.2013.07.033. PubMed DOI

Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., et al. Bile acids: Natural ligands for an orphan nuclear receptor. Science. 1999;284:1365–1368. doi: 10.1126/science.284.5418.1365. PubMed DOI

Collins J.L., Parks D.J. Constitutive Androstane Receptor. Patent WO 2001071361 A2. 2001

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...